{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:13:49Z","timestamp":1793146429405,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Leipzig"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11695-026-08690-6","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:21:02Z","timestamp":1776792062000},"page":"2976-2986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of RYGB Limb Lengths on HbA1c in Patients with Obesity and Type 2 Diabetes"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-7735","authenticated-orcid":false,"given":"Lena","family":"Seidemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Morgenroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusef","family":"Moulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Undine Gabriele","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestis","family":"Lyros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Petroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Prettin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0724-3825","authenticated-orcid":false,"given":"Norbert","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"8690_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","unstructured":"GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"Lancet"},{"key":"8690_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","volume":"397","author":"G Mingrone","year":"2021","unstructured":"Mingrone G, Panunzi S, de Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(20)32649-0.","journal-title":"Lancet"},{"key":"8690_CR3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","volume":"34","author":"WA Brown","year":"2024","unstructured":"Brown WA, Liem R, Al-Sabah S, Anvari M, Boza C, Cohen RV, et al. Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg. 2024;34:1764\u201377. https:\/\/doi.org\/10.1007\/s11695-024-07196-3.","journal-title":"Obes Surg"},{"key":"8690_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11695-016-2457-9","volume":"27","author":"F Rubino","year":"2017","unstructured":"Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KGMM, Zimmet PZ, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by International Diabetes Organizations. Obes Surg. 2017;27:2\u201321. https:\/\/doi.org\/10.1007\/s11695-016-2457-9.","journal-title":"Obes Surg"},{"key":"8690_CR5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.jviscsurg.2022.12.010","volume":"160","author":"P Topart","year":"2023","unstructured":"Topart P. Obesity surgery: which procedure should we choose and why? J Visc Surg. 2023;160:S30-7. https:\/\/doi.org\/10.1016\/j.jviscsurg.2022.12.010.","journal-title":"J Visc Surg"},{"key":"8690_CR6","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1007\/s11695-020-04796-7","volume":"30","author":"P Kumar","year":"2020","unstructured":"Kumar P, Yau H-C, Trivedi A, Yong D, Mahawar K. Global variations in practices concerning Roux-en-Y gastric bypass-an online survey of 651 bariatric and metabolic surgeons with cumulative experience of 158,335 procedures. Obes Surg. 2020;30:4339\u201351. https:\/\/doi.org\/10.1007\/s11695-020-04796-7.","journal-title":"Obes Surg"},{"key":"8690_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11695-019-04032-x","volume":"29","author":"M Bhandari","year":"2019","unstructured":"Bhandari M, Fobi MAL, Buchwald JN. Standardization of bariatric metabolic procedures: world consensus meeting statement. Obes Surg. 2019;29:309\u201345. https:\/\/doi.org\/10.1007\/s11695-019-04032-x.","journal-title":"Obes Surg"},{"key":"8690_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.soard.2023.04.298","volume":"19","author":"EM Aleassa","year":"2023","unstructured":"Aleassa EM, Papasavas P, Augustin T, Khorgami Z, Benson-Davies S, Ghiassi S, et al. American Society for Metabolic and Bariatric Surgery literature review on the effect of Roux-en-Y gastric bypass limb lengths on outcomes. Surg Obes Relat Dis. 2023;19:755\u201362. https:\/\/doi.org\/10.1016\/j.soard.2023.04.298.","journal-title":"Surg Obes Relat Dis"},{"key":"8690_CR9","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.2337\/dc22-0835","volume":"45","author":"Y Kwon","year":"2022","unstructured":"Kwon Y, Lee S, Kim D, ALRomi A, Park S-H, Lee CM, et al. Biliopancreatic limb length as a potential key factor in superior glycemic outcomes after Roux-en-Y gastric bypass in patients with type 2 diabetes: a meta-analysis. Diabetes Care. 2022;45:3091\u2013100. https:\/\/doi.org\/10.2337\/dc22-0835.","journal-title":"Diabetes Care"},{"key":"8690_CR10","unstructured":"Deutsche Gesellschaft f\u00fcr Allgemein- und Viszeralchirurgie e.V. (DGAV). S3-Leitlinie Chirurgie der Adipositas und metabolischer Erkrankungen: Registernummer 088\u2009\u2013\u2009001; 2018."},{"key":"8690_CR31","doi-asserted-by":"publisher","unstructured":"Lange UG, Moulla Y, Sch\u00fctz T, Bl\u00fcher M, Peter V, Shang E, Dietrich A. Effectiveness and Tolerability of a Two-Week Hypocaloric Protein-Rich Diet Prior to Obesity Surgery with Two Different Diet Interventions: a Prospective Randomized Trial. Obes Surg. 2022;32:2903\u201313. https:\/\/doi.org\/10.1007\/s11695-022-06180-z.","DOI":"10.1007\/s11695-022-06180-z"},{"key":"8690_CR11","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","volume":"366","author":"PR Schauer","year":"2012","unstructured":"Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567\u201376. https:\/\/doi.org\/10.1056\/NEJMoa1200225.","journal-title":"N Engl J Med"},{"key":"8690_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","volume":"29","author":"SL Samson","year":"2023","unstructured":"Samson SL, Vellanki P, Blonde L, Christofides EA, Galindo RJ, Hirsch IB, et al. American Association of Clinical Endocrinology Consensus Statement: comprehensive type 2 diabetes management algorithm\u2009\u2212\u20092023 update. Endocr Pract. 2023;29:305\u201340. https:\/\/doi.org\/10.1016\/j.eprac.2023.02.001.","journal-title":"Endocr Pract"},{"key":"8690_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110069","volume":"192","author":"T-E Wu","year":"2022","unstructured":"Wu T-E, Su Y-W, Chen H-S. Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2022;192:110069. https:\/\/doi.org\/10.1016\/j.diabres.2022.110069.","journal-title":"Diabetes Res Clin Pract"},{"key":"8690_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ahj.2021.10.181","volume":"243","author":"SV Arnold","year":"2022","unstructured":"Arnold SV, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, et al. Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study. Am Heart J. 2022;243:232\u20139. https:\/\/doi.org\/10.1016\/j.ahj.2021.10.181.","journal-title":"Am Heart J"},{"key":"8690_CR15","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.2337\/dc24-S002","volume":"47","author":"2","year":"2024","unstructured":"2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S20\u201342. https:\/\/doi.org\/10.2337\/dc24-S002.","journal-title":"Diabetes Care"},{"key":"8690_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11695-014-1339-2","volume":"25","author":"TM English","year":"2015","unstructured":"English TM, Malkani S, Kinney RL, Omer A, Dziewietin MB, Perugini R. Predicting remission of diabetes after RYGB surgery following intensive management to optimize preoperative glucose control. Obes Surg. 2015;25:1\u20136. https:\/\/doi.org\/10.1007\/s11695-014-1339-2.","journal-title":"Obes Surg"},{"key":"8690_CR17","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2337\/dc24-S008","volume":"47","author":"8","year":"2024","unstructured":"8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47:S145\u201357. https:\/\/doi.org\/10.2337\/dc24-S008.","journal-title":"Diabetes Care"},{"key":"8690_CR18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2337\/dc16-0954","volume":"39","author":"DJM Isaman","year":"2016","unstructured":"Isaman DJM, Rothberg AE, Herman WH. Reconciliation of type 2 diabetes remission rates in studies of Roux-en-Y gastric bypass. Diabetes Care. 2016;39:2247\u201353. https:\/\/doi.org\/10.2337\/dc16-0954.","journal-title":"Diabetes Care"},{"key":"8690_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59050985","author":"V Balasubaramaniam","year":"2023","unstructured":"Balasubaramaniam V, Pouwels S. Remission of type 2 diabetes mellitus (T2DM) after sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), and Roux-en-Y gastric bypass (RYGB): a systematic review. Med (Kaunas). 2023. https:\/\/doi.org\/10.3390\/medicina59050985.","journal-title":"Med (Kaunas)"},{"key":"8690_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-002033","author":"E Stenberg","year":"2021","unstructured":"Stenberg E, Olbers T, Cao Y, Sundbom M, Jans A, Ottosson J, et al. Factors determining chance of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a nationwide cohort study in 8057 Swedish patients. BMJ Open Diabetes Res Care. 2021. https:\/\/doi.org\/10.1136\/bmjdrc-2020-002033.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"8690_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jamcollsurg.2019.09.012","volume":"230","author":"BM Pessoa","year":"2020","unstructured":"Pessoa BM, Browning MG, Mazzini GS, Wolfe L, Kaplan A, Khoraki J, et al. Factors mediating type 2 diabetes remission and relapse after gastric bypass surgery. J Am Coll Surg. 2020;230:7\u201316. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2019.09.012.","journal-title":"J Am Coll Surg"},{"key":"8690_CR22","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1007\/s11695-018-3421-7","volume":"28","author":"J Homan","year":"2018","unstructured":"Homan J, Boerboom A, Aarts E, Dogan K, van Laarhoven C, Janssen I, et al. A longer biliopancreatic limb in Roux-en-Y gastric bypass improves weight loss in the first years after surgery: results of a randomized controlled trial. Obes Surg. 2018;28:3744\u201355. https:\/\/doi.org\/10.1007\/s11695-018-3421-7.","journal-title":"Obes Surg"},{"issue":"2","key":"8690_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.soard.2007.08.006","volume":"4","author":"AK Madan","year":"2008","unstructured":"Madan AK, Harper JL, Tichansky DS. Techniques of laparoscopic gastric bypass: on-line survey of American Society for Bariatric Surgery practicing surgeons. Surg Obes Relat Dis. 2008;4(2):166\u201372. https:\/\/doi.org\/10.1016\/j.soard.2007.08.006.","journal-title":"Surg Obes Relat Dis"},{"key":"8690_CR24","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s11695-011-0409-y","volume":"21","author":"L Orci","year":"2011","unstructured":"Orci L, Chilcott M, Huber O. Short versus long Roux-limb length in Roux-en-Y gastric bypass surgery for the treatment of morbid and super obesity: a systematic review of the literature. Obes Surg. 2011;21:797\u2013804. https:\/\/doi.org\/10.1007\/s11695-011-0409-y.","journal-title":"Obes Surg"},{"key":"8690_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008859","volume":"96","author":"M Nora","year":"2017","unstructured":"Nora M, Morais T, Almeida R, Guimar\u00e3es M, Monteiro MP. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes? Medicine (Baltimore). 2017;96:e8859. https:\/\/doi.org\/10.1097\/MD.0000000000008859.","journal-title":"Medicine (Baltimore)"},{"key":"8690_CR26","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.soard.2015.02.011","volume":"11","author":"TP Guedes","year":"2015","unstructured":"Guedes TP, Martins S, Costa M, Pereira SS, Morais T, Santos A, et al. Detailed characterization of incretin cell distribution along the human small intestine. Surg Obes Relat Dis. 2015;11:1323\u201331. https:\/\/doi.org\/10.1016\/j.soard.2015.02.011.","journal-title":"Surg Obes Relat Dis"},{"key":"8690_CR27","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.soard.2021.01.041","volume":"17","author":"M Hinds\u00f8","year":"2021","unstructured":"Hinds\u00f8 M, Svane MS, Hedb\u00e4ck N, Holst JJ, Madsbad S, Bojsen-M\u00f8ller KN. The role of GLP-1 in postprandial glucose metabolism after bariatric surgery: a narrative review of human GLP-1 receptor antagonist studies. Surg Obes Relat Dis. 2021;17:1383\u201391. https:\/\/doi.org\/10.1016\/j.soard.2021.01.041.","journal-title":"Surg Obes Relat Dis"},{"issue":"Suppl 1","key":"8690_CR28","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1038\/ijo.2009.15","volume":"33","author":"DE Cummings","year":"2009","unstructured":"Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond). 2009;33(Suppl 1):S33\u201340. https:\/\/doi.org\/10.1038\/ijo.2009.15.","journal-title":"Int J Obes (Lond)"},{"key":"8690_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/s41366-018-0117-y","volume":"43","author":"BG Patr\u00edcio","year":"2019","unstructured":"Patr\u00edcio BG, Morais T, Guimar\u00e3es M, Veedfald S, Hartmann B, Hilsted L, et al. Gut hormone release after gastric bypass depends on the length of the biliopancreatic limb. Int J Obes (Lond). 2019;43:1009\u201318. https:\/\/doi.org\/10.1038\/s41366-018-0117-y.","journal-title":"Int J Obes (Lond)"},{"key":"8690_CR30","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.clnu.2017.01.022","volume":"37","author":"K Dogan","year":"2018","unstructured":"Dogan K, Homan J, Aarts EO, Boer H, van Laarhoven CJHM, Berends FJ. Long-term nutritional status in patients following Roux-en-Y gastric bypass surgery. Clin Nutr. 2018;37:612\u20137. https:\/\/doi.org\/10.1016\/j.clnu.2017.01.022.","journal-title":"Clin Nutr"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08690-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08690-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08690-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:30:47Z","timestamp":1781649047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08690-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["8690"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08690-6","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was registered at German Clinical Trials Register Freiburg (ID: DRKS00007810) and approved by Leipzig University\u2019s ethics committee (153\/15-ek). It was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice, and was monitored by Leipzig University\u2019s Clinical Trial Centre. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics, Consent to Participate Statement and Ethical Approval"}},{"value":"Matthias Bl\u00fcher received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Lilly, Novo Nordisk, Novartis, and Sanofi. No other disclosures were reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}